ИНДИВИДУАЛЬНАЯ УСТОЙЧИВОСТЬ СТЕРЕОТИПОВ ИММУННОГО РЕАГИРОВАНИЯ И СОВРЕМЕННЫЕ ВОЗМОЖНОСТИ ИХ ДИАГНОСТИКИ ПРИ ТРАНСПЛАНТАЦИИ ОРГАНОВ (ИММУНО-ФИЗИОЛОГИЧЕСКИЙ АНАЛИЗ ПРОБЛЕМЫ)

стереотипы иммунного ответа, трансплантация органов, биомаркеры

1. Sayegh M.H., Carpenter C.B. Transplantation 50 Years Later – Progress, Challenges, and Promises. 2004 // The New England Journal of Medicine. 2004; 26; 351: 2761– 2766. Phillip Scott 2005.

2. Tryphonopoulos P., Ruiz P., Weppler D. Long-term fol- low-up of 23 operational tolerant liver transplant reci- pients // Transplantation. 2010 Dec 27; 90 (12): 1556– 1561.

3. Hubscher S. What Does the Long-Term Liver Allograft Look Like for the Pediatric Recipient? // Liver Trans- plantation. 2009; 15: S19–S24.

4. Feng S., Ekong U., Lobritto D. Complete Immunosup- pression Withdrawaland Subsequent Allograft Function Among Pediatric Recipientsof Parental Living Donor Liver Transplants // JAMA. January 18, 2012; 307 (3): 283–293.

5. Sommerer C., Giese T., Meuer S., Zeier M. Pharmaco- dynamic monitoring of calcineurin inhibitor therapy: Is there a clinical benefit? // Nephro. Dial. Transplant. 2009; 24: 21–27.

6. Nafady-Hego H., Li Y., Ohe H., Zhao X., Satoda N. The Generation of donor-specific CD4+CD25+CD45RA+ naive regulatory T-cells in operationally tolerant patients after pediatric living-donor liver transplantation // Trans-

7. plantation. 2010; 90: 1547–1555.

8. Girlanda R., Kirk A.D. Frontiers in Nephrology: Im-

9. mune Tolerance to Allografts in Humans // J. Am. Soc.

10. Nephrol. 2007; 18: 2242–2251.

11. Starzl T.E., Lakkis F.G. The Unfinished legacy of liver

12. transplantation // Emphasis on Immunology Hepatology.

13. ; 43: 151–163.

14. Kryzhanovsky G.N. The Basis of common pathophysio-

15. logy. M.: Med. inform agency, 2011: 252.

16. Jin Bo, Sun Tao, Yu Xiao-Hong The Effects of TLR Ac- tivation on T-Cell Development and Differentiation // Clinical and Developmental Immunology 2012 Volume

17. , Article ID 836485: 32.

18. Alegre M.-L., Goldstein D.R. and Chong A.S. Toll-like

19. receptor signaling in transplantation // Curr. Opin. Or-

20. gan. Transplant. 2008 August; 13 (4): 358–365.

21. Louis J., Gumy A., Voigt H. Experimental cutaneous Leishmaniasis: a powerful model to study in vivo the mechanisms underlying genetic differences in Th sub- set differentiation // European J. of Dermatology. 2002;

22. (4): 316.

23. Scott P. Immunologic memory in cutaneous leishmania-

24. sis // Cell. Microbiol. Dec. 2005; 7 (12): 1707–1713.

25. Okwor I., Liu D., Beverley S.M., Uzonn J.E. Inoculation of killed Leishmania major into immune mice rapidly disrupts immunity to a secondary challenge via IL-10- mediated process // PNAS. 2009 August 18; 106 (33):

26. –13956.

27. Colpitts S.L., Scott P. The early generation of a hetero-

28. geneous CD4+ T-cell response to Leishmania major //

29. J. Immunol. 2010. August 15; 185 (4): 2416–2423.

30. Van Belle T.L., Coppieter K.T., Von Herrath M.G. Type 1 Diabetes: Etiology, Immunology and Therapeutic Strate-

31. gies // Physiol. Rev. 2011; 91: 79–118.

32. Heidt S., San Segundo D., Wood K.J. The impact of

33. TH17 cells on transplant rejection and theInduction of tolerance // Curr. Opin. Organ. Transplant. 2010. August; 15 (4): 456–461.

34. Seetharama A., Venkataswarup T., Mohanakumar T. Al loimmunity and autoimmunity in chronic rejection // Curr. Opin. Organ. Transplant. 2010. August; 15 (4): 531–536.

35. Dudai Y. Predicting not to predict too much: how the cellular machinery of memory anticipatesthe uncertain future // Phil. Trans. R. Soc. B. 2009; 364: 1255–1262.

36. Gautier S.V. Immunosuppression at transplantation of solid organs. M.: Triada, 2011: 470.

37. Zhai Y., Busuttil R.W. and Kupiec-Weglinski J.W. Liver Ischemia and Reperfusion Injury: New Insights into Me- chanisms of Innate-Adaptive Immune-Mediated Tissue Inflammation // Am. J. Transplant. 2011; 11: 1563–1569.

38. Mullally A., Ritz J. Hematopoietic stem cell transplanta- tion Beyond HLA: the significance of genomic variation for allogeneic // Blood. 2007, 15 February; 109, Number.

39. Keller M.R., Burlingham W.J. Loss of tolerance to self after transplant Semin Immunopathol. 2011 March; 33 (2): 105–110.

40. Ford M.L., Kirk A.D., Larsen C.P. Donor-Reactive T-Cell Stimulation History and Precursor Frequency: Barriers

41. to Tolerance Induction // Transplantation. 2009 May 15;

42. (9 Suppl): S69–S74.

43. Krummey S.M., Ford M.L. Heterogeneity within T-Cell

44. Memory: Implications for Transplant Tolerance // Front

45. Immunol. 2012; 3: 36–42.

46. D’Orsogna L.J., Roelen D.L., Doxiadis I.I.N.,

47. Claas F.H.J. TCR cross-reactivity and allorecognition: new insightsinto the immunogenetics of allorecognition Immunogenetics. 2012; 64: 77–85.

48. Page A.J., Ford M.L., Kirk A.D. Memory T-Cell-Specific Therapeutics in Organ Transplantation // Curr. Opin. Or- gan. Transplant. 2009 December; 14 (6): 643–649.

49. Augustinea J.J., Siua D.S., Clementeb M.J. Pre-Transp- lant IFN-γ ELISPOTs Are Associated with Post-Transp- lant Renal Function in African American Renal Transp- lant Recipients // Am. J. Transplant. 2005; 5: 1971–1975.

50. Miller D.M., Thornley T.B., Greiner D.L., Rossini A.A. Viral Infection: A Potent Barrier to Transplantation Tole- rance // Clinical and Developmental Immunology, 2008, Article ID 742810, 14 pages doi:10.1155/2008/742810.

51. Benseler V., Warren A., Vo M. Hepatocyte entry leads to degradation of autoreactive CD8 T cells // PNAS. Octo- ber 4, 2011; 108 (40): 16735–16740.

52. Von Oppen N., Schurich A., Hegenbarth S. Systemic Antigen Cross-Presented by Liver Sinusoidal Endothe- lial Cells Induces Liver-Specific CD8 T-Cell Retention and Tolerization // Hepatology. 2009; 49: 1664–1672.

53. Crispe N.I. Liver Antigen-Presenting Cells // Hepatolo- gy. 2011 February; 54 (2): 357–365.

54. Jones N.D. Memory T cells: How might they disrupt the induction of tolerance? // Transplantation. 2009 May 15; 87 (9 Suppl): S74–S77.

55. Pearl J.P., Parris J., Hale D.A. Immunocompetent T- cells with a memory-like phenotype are the dominant- cell type following antibody-mediated T-cell depletion // Am. J. Transplant. 2005; 5: 465–474.

56. Ohe H., Waki K., Yoshitomi M. Factors affecting opera- tional tolerance after pediatric living-donor liver trans- plantation: impact of early post-transplant events and HLA match // European Society for Organ Transplantati- on. 2012; 25: 97–106.

57. Kurian S.M., Heilman R., Mondala T.S. Biomarkers for Early and Late Stage Chronic Allograft Nephropathy by Proteogenomic Profiling of Peripheral Blood. PLoS ONE. July 2009; 4, Issue 7, e6212, 1–11.

58. Demetris A.J., Lunz J.G., Randhawa P. Monitoring of human liver and kidney allograft tolerance:a tissue/hi- stopathology perspective 2008 European Society for Or- gan // Transplantation. 2009; 22: 120–141.

59. Reding R., Gras J., Truong D.Q. The Immunological Monitoring of Alloreactive Responses in Liver Trans- plant Recipients: A Review // Liver Transplantation. 2006; 12: 373–383.

60. Najafian N., Albin M.J., Newell K.A. How Can We Mea- sure Immunologic Tolerance in Humans? // J. Am. Soc. Nephrol. 2006; 17: 2652–2663.

61. Martınez-Llordella M., Puig-Peya I., Orlando G. Mul- tiparameter Immune Profiling of Operational Tolerance in Liver Transplantation // Am. J. Transplant. 2007; 7: 309–319.

62. Perkins D., Verma M., Park K.J. Advances of genomic science and systems biology in renal transplantation: a review // Semin. Immunopathol. 2011; 33: 211–218.

63. Sigdel T.K., Sarwal M.M. Recent advances in biomarker discovery in solid organ transplant by proteomics // Ex- pert Rev. Proteomics. 2011. December; 8 (6): 705–715.

64. Hibi T., Nishida S., Garcia J., Tryphonopoulos P. Ci- trulline Level Is a Potent Indicator of Acute Rejection in the Long Term Following Pediatric Intestinal/Multivis- ceral Transplantation // Am. J. Transplant. 2012; 12: S4. P. 27–32.

65. Siawaya J.F.D., Roberts T., Babb C. An Evaluation of Commercial Fluorescent Bead-Based Luminex Cytokine Assays. 2008 PLoS ONE 3 (7): e2535.

66. Mazariegos G.V. Immunosuppression withdrawal after Liver Transplantation; what are the next steps // Trans- plantation. 2011; 91: 697–699.

67. Бугров А.В. Клиническое значение лабораторных маркеров sCD30 и РАРР-А при трансплантации серд- ца: Автореф. дис. ... к. м. н. М., 2011: 26.

68. Bougrov A.V. Clinical importance of s CD 30 and PAAP- A markers at heart transplantation: Autroprecis of the- sis ... on cand. med. sci. M., 2011: 26.

69. Орлова О.В. Роль маркеров воспаления, тромбообра- зования, неоангиогенеза и апоптоза в прогнозирова- нии и развитии васкулопатии трансплантированного сердца: Автореф. дис. ... д. м. н. М., 2009: 50.

70. Orlova O.V. Role of markers of inflammation, trombosis, neoangiogenesis and apoptosis in prognostication of vas- culopatia of transplantated heart: Autoprecis of thesis ... on doct. med. sci. M., 2009: 50.

71. Пищулин M. Диагностическое и прогностическое значение неоптерина и sCD30 при трансплантации печени: Автореф. дис. ... к. б. н. М., 2012: 25. Pischulina M. Diagnostic and prognostic importance of neopterin and s CD-30 at liver transplantation: Autopre- cis of thesis ... on cand. boil. sci. M., 2012: 25.

72. Шевченко О.П., Долгов В.В., Гичкун О.Е., Кунце- вич Н.В., Цирульникова О.М., Готье С.В. Гомоцис- теин при трансплантации печени детям раннего возраста // Вестн. транспл. и искусств. орг. 2012; (4): 44–47.

73. Shevchenko O.P., Dolgov V.V., Gichkun O.E., Kunce- vich N.V., Tsirulnikova O.M., Gautier S.V. Homocysteine after liver transplantation in children // Vestn. transpl. i iskus. org. 2012; (4): 44–47.

74. Шевченко О.П., Цирульникова О.М., Бугров А.В., Лурье Ю.Э., Цирульникова И.Е., Мнацаканян Д.С., Гичкун О.Е., Готье С.В. Инсулиноподобный фактор роста-1 при трансплантации печени детям с врож- денными и наследственными заболеваниями гепа- тобилиарной системы // Вестн. транспл. и искусств. орг. 2012; (1): 50–55.

75. Shevchenko O.P., Tsirulnikova O.M., Bougrov A.V., Lou- rie Y.E., Tsirulnikova I.E., Mnatsakanyan D.S., Gich- kun O.E., Gautier S.V. Insulin-like growth factor-1 after orthotopic liver transplantation in children with conge-

76. nital and hereditary diseases of hepatobiliary system //

77. Vestn. transpl. i iskus. org. 2012; (1): 50–55.

78. Шевченко О.П., Цирульникова О.М., Гичкун О.Е., Макарова Л.В., Цирульникова И.Е., Ахаладзе Д.Г., Шмерко Н.П., Готье С.В. Прогностическое значение растворимой формы лиганда CD40 при трансплан- тации печени детям с врожденными и наследствен- ными заболеваниями гепатобилиарной системы //

79. Вестн. транспл. и искусств. орг. 2012; (2): 15–19.

80. Shevchenko O.P., Tsirulnikova O.M., Gichkun O.E., Ma- karova L.V., Tsirulnikova I.E., Akhaladze D.G., Shmer- ko N.P., Gautier S.V. Prognostic value of soluble CD40 ligand after liver transplantation in children with conge- nital and hereditary diseases of hepatobiliary system // Vestn. transpl. i iskus. org. 2012; (2): 15–19.

81. Kim K.H., Oh E.Y., Yung E.S. Evaluation of pre and post transplantation serum interferongamma and soluble CD30 for predicting liver allograft rejection // Transp- lant. Proceed. 2006; 38: 1429–1143.

82. Weimer R., Susal C., Iildiz S., Staak A., Pelzl S., Ren- ner F., Dietrich H. Posttransplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens // Am. J. Transp- lant. 2006. Aug; 6 (8): 1865–1874.

83. Крыжановский Г.Н. Основы общей патофизиологии. М.: Мед. информ. агентство, 2011: 252.

84. Kryzhanovsky G.N. Bases of the general pathophysiolo- gy. M.: Med. inform. agency, 2011: 252.

85. Virmani R., Kolodgie F.D., Burke A.P. Atherosclerotic plague progression and vulnezability to rupture: angio- genesis as a source of intraplague hemorrhage // Arterio- scler. thromb. Vasc. Biol. 2005; 25: 2054–2061.

86. Adeyi O., Fischer S.E., Guindi M. Liver allograft patho- logy: approach to interpretation of needle biopsies with clinicopathological correlation // J. Clin. Pathol. 2010; 63: 47–74.

87. Sallusto F., Lanzavecchia A. Heterogeneity of CD4 me- mory T-cells: Functionalmodules for tailored immuni- ty // Eur. J. Immunol. 2009; 39: 2076–2082.

88. Sakaguchi S., Wing K., Miyara M. Regulatory T-cells – a brief history and perspective // Eur. J. Immunol. 2007; 37: S116–123.

89. Frommer F., Heinen T.J., Wunderlich T. Tolerance wi- thout Clonal Expansion: Self-Antigen-Expressing B- Cells Program Self-Reactive T-Cells for Future Deleti- on // The Journal of Immunology. 2008; 181: 5748–5759.

90. Marshall N.B., Swain S.L. Cytotoxic CD4 T-Cells in An- tiviral Immunity // Journal of Biomedicine and Biotech- nology. 2011; 2011. Article ID 954602: 8.

91. Janson P.C., Linton L.B., Bergman E.A., Marits P. Pro- filing of CD4+ T-cells with epigenetic immune lineage analysis // J. Immunol. 2011. Jan 1; 186 (1): 92–102.

92. Schrage A., Wechsung K., Neumann K. Enhanced T- Cell Transmigration Across the MurineLiver Sinusoidal Endothelium Is Mediated by Transcytosis and Surface Presentation of Chemokines // Hepatology. 2008; 48: 1262–1272.